• <sub id="w5dj7"><xmp id="w5dj7"><track id="w5dj7"></track>
  • <option id="w5dj7"><li id="w5dj7"><option id="w5dj7"></option></li></option>
  • <xmp id="w5dj7"><center id="w5dj7"></center></xmp>
  • <sub id="w5dj7"></sub>
  • <sub id="w5dj7"></sub>
  • <progress id="w5dj7"><center id="w5dj7"><tbody id="w5dj7"></tbody></center></progress> <sub id="w5dj7"></sub>
  • <track id="w5dj7"><li id="w5dj7"></li></track>
  • <track id="w5dj7"><noframes id="w5dj7"><track id="w5dj7"></track>
  • <nav id="w5dj7"><xmp id="w5dj7"><track id="w5dj7"></track><track id="w5dj7"></track>
  • HyClone̥ţѪSH30084.03

    rԪ

    Ҏ 500ML 500MLX10

    “ϵʽI47-825O-882O

    ¡FBSaƷϢ

    aƷQ: HyClone̥ţѪ()HyClone̥ţѪ HyCloneĴ̥ţѪHyCloneFBSHyCloneĴFBS HyClone FBS()HyClone FBS(Ĵ)¡̥ţѪ()¡̥ţѪ¡FBS
    ӢQ: HyClone Fetal Bovine Serum, Characterized, Australian origin. HyClone FBS, Characterized, Australian origin.
    aƷ؛̖: SH30084.03
    Ѫȼ: Characterized FBS
    ȼfHyclone̥ţѪ壨Characterized FBS܉M󲿷ֵͬÑ̥ţѪͨ^3100nmVĤ^VķʹѪo̥ţѪ彛^ˇăȶغѪtؙzy܉еȵļﻯW
    ̎ʽ: ˜100 nmVĤ^V
    ؅^Դ: Ĵ
    NԴ: ̥ţ
    ȶˮƽ: ≤25 EU/ml
    Ѫtˮƽ ≤25 mg/dl
    δ
    x δzy
    ֧ԭw
    aƷҎ: 500 ML
    l: -5 to -20°C
    \ݔʽ: ɱ\ݔ
    aƷ:
    Hyclone̥ţѪѪԴ԰Ĵͨ^USDA߰ĴAQISCJCĴԭVĠIBͽṩ˃ԽLhͬrһ]čuZطڄRĿƺ͹@CѪԴĮaƷ|
     
    Hyclone̥ţѪ壨Characterized FBS,Australian OriginaƷc£ ȫĮaƷԴ׷ۙѪпwȵͶLSTPgCƿcƿ֮gСIJͨ^rIUSDAJC
     
    ¡̥ţѪSH30084.3|dz;^V mڸNFԭɼ̥ɼg|ɼȣ B
    Ԫr $1000 / ƿGE Lifesciences
    aƷDƬ Hyclone̥ţѪFBS 16000044
    Hyclone̥ţѪFBSDƬ


    LN۵Hyclone̥ţѪȫM1ƒȳFκήaƷ|} ˓Q!

    W΢ȦqqȺlͽoͷIȡMHyclone̥ţѪ b20mlԇbԇÝMُI


    Hyclone¡̥ţѪʹ÷

    ڼB^5%-20%̥ţѪʹõHyclone̥ţѪ10%ߝȵѪܸ׃Ļ_VӰ푺mĽY҂ڌʹ10%ĺ¡̥ţѪB293TЧdzЩҲʹ5%Hyclone FBS20%Hyclone̥ţѪҪw xmHyclone̥ţѪ

    Hyclone̥ţѪ屣淽

    1ҪLڱѪ횃-20 - 70 ͜ر4бrg^1Ѫ 37̫,tѪ׃Ü,ͬrѪеЧɷ֕ƉӰѪ|һΟoһƿ, 4045mlbڟo50mlxĹѪYrweӼs10%,,Ѫڃ͜رǰAһ weg,tװlȾƿ
     
    2һSṩѪo,o^VlFѪБҸ,tɌѪBҺһ^V,ֱ ^VѪ
     
    3ƿbѪ𲽽:-20 -70 ͜رеѪ4ܽ1.ȻҜ,ȫ ܽٷb,һ50mloxĹܿɷb4045mlܽ^Ҏtuξ(Сɚ),ʹض cɷ־һ,pİl.ֱӌѪ-20M37,@ضȸ׃̫,ɵ| F
     
    4ָ56, 30犼ӟȫѪ.ӟ^Ҏtuξ.˟̎ĿʹѪеaw ɷ֜.DZ,һ㲻h˟̎,̎Ѫ@,߀ӰѪ|.aw c:, ƽտs, ʴ󼚰ѪСጷŽM, , Mܰͼ;ɼ lWڅͻ
     
    5Ѫеij :ҪѪе֬׃ԼѪwS,@ЩﲻӰѪ屾 |.x3000rpm,5ȥ,Ҳɲ̎ @΢R"Сc":^̎^Ѫ, γɕ@Щ@΢R^"Сc",`JѪȾһr,С cӰ푼L,Ѫ|,tֹͣʹ,Qһ̖Ѫ
     

    Hyclone¡ѪaƷփPDFļd

    Hyclone¡̥ţѪFBSaƷփ
    Hyclone¡̥ţѪf

    Hyclone̥ţѪ壨¡FBSͼBxָ

    Hyclone̥ţѪFBS
    ؼ̥ţѪ壨Defined FBS
    Ҏ ؛̖
    ̥ţѪ壨Defined FBS, ѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    500 mL SH30070.03
    ̥ţѪ壨Characterized FBS
    Ҏ ؛̖
    ̥ţѪ壨Characterized FBS, ѪԴ
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    500 mL SH30071.03
    ̥ţѪUSDACUSDA Tested FBS
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    ͨ^ţazyѪԴԸ˹_鶼˹R_߶ΣR
    500 mL SH30910.03
    ̥ţѪ壨Characterized FBS, ôѪԴ
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    500 mL SH30396.03
    ̥ţѪ壨Characterized FBS, mѪԴ
    3 x 100 nmo^V
    ȶ≤20 EU/mLѪt≤25 mg/dL
    500 mL SH30406.02
    ̥ţѪ壨Characterized FBS, ѪԴ
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    500 mL SH30084.03
    ̥ţѪ壨Characterized FBS, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤25 mg/dL
    500 mL SV30160.03
    ˜ʼ̥ţѪ壨Standard FBS
    Ҏ ؛̖
    ̥ţѪ壨Standard FBS, ѪԴ
    3 x 100 nmo^V
    ȶغѪt^zyӛ
    ͨ^ţaBVDzy
    500 mL SH30088.03
    ;̥ţѪ壨Specialty FBS
    Ҏ ؛̖
    ̥̿̎ţѪ壨Charcoal/Dextran Treated FBS, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤20 mg/dL
    500 mL SH30068.03
    ͸̥ţѪ壨Dialyzed FBS ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    ≤ Mr 10 000
    500 mL SH30079.03
    IgG̥ţѪ壨Super Low IgG FBS, ѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    IgG: ≤ 5 μg/mL
    500 mL SH30898.03
    ̥ţѪ壨Screened FBS
    Ҏ ؛̖
    ES̥ţѪ壨ES Cell Screened FBS, ѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    500 mL SH30070.03E
    ˹g|ɼ̥ţѪ壨Human Mesenchymal Stem Cell Screened FBSѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    500 mL SH30070.03M
    ĭh̥ţѪ壨Tetracycline Screened FBS, ѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    500 mL SH30070.03T
    x̥ţѪ壨Insect Cell Screened FBS, ѪԴ
    40 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    500 mL SH30070.03I
    СţѪ壨Bovine Calf Sera
    Ҏ ؛̖
    СţѪ壨Bovine Calf Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10mg/dL
    16-22Сţ
    500 mL SH30073.03
    aFxСţѪ壨Iron-Supplemented Bovine Calf SerumѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    16-22Сţ
    500 mL SH30072.03
    ţѪ壨Newborn Calf Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤50 EU/mLѪt≤25 mg/dL
    Գ10ȵţ
    500 mL SH30118.03
    mţѪ壨New Zealand Newborn Bovine Calf Serum
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    Գ씵С10ţ
    500 mL SH30401.01
    maFxСţѪ (New Zealand Iron Supplemented Newborn Serum)
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    Գ씵С10ţ
    500 mL SH30626.02
    Ѫ壨Engineered sera
    Ҏ ؛̖
    ţѪ壨Alpha Calf Fraction, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤20 mg/dL
    500 mL SH30212.03
    FetalClone I Ѫ壨FetalClone IѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤20 mg/dL
    ᘌshybridoma cells˃
    500 mL SH30080.03
    FetalClone II Ѫ壨FetalClone IIѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤20 mg/dL
    ᘌCHO-K1CHOϵмB˃
    500 mL SH30066.03
    FetalClone III Ѫ壨FetalClone IIIѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤20 mg/dL
    mڴ󲿷ּᘌwSfibroblasts ells˃
    500 mL SH30109.03
    NţѪ壨Alternatives
    Ҏ ؛̖
    LСţѪ壨Bovine Growth Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    16-22Сţ
    500 mL SH30541.03
    ӏСţѪ壨Cosmic Calf Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    16-22Сţ
    500 mL SH30087.03
    mӏţѪ壨New Zealand Cosmic Calf Serum
    3 x 100 nmo^V
    ȶ≤25 EU/mLѪt≤25 mg/dL
    Գ씵С10ţ
    500 mL SH30413.02
    NخѪ壨Species-specific sera
    Ҏ ؛̖
    wţѪ壨Donor Adult Bovine Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤50 EU/mLѪt≤25 mg/dL
    Գ씵С36µijţ
    500 mL SH30075.03
    wRѪ壨Donor Equine SerumDonor Horse Serum, ѪԴ
    3 x 100 nmo^V
    ȶ≤10 EU/mLѪt≤10 mg/dL
    Գ씵6µijR
    500 mL SH30074.03
    miѪ壨New Zealand Porcine Serum
    3 x 200 nmo^Vݗ
    ȶ≤100 EU/mLѪt≤50 mg/dL
    Գ씵6µiji
    1000 mL SH30908.04
    BMedia
    Ҏ ؛̖
    RPMI 1640 Medium
    with 25 mM Hepes and L-glutamine
    500 mL SH30255
    DMEM
    with high glucose, 4.0 mM L-glutamine, and sodium pyruvate
    500 mL SH30243
    DMEM
    with high glucose and 4.0 mM L-glutamine • without sodium pyruvate
    500 mL SH30022
    DMEM
    with high glucose • without L-glutamine and sodium pyruvate
    500 mL SH30081
    DMEM
    with high glucose and L-glutamine • without sodium pyruvate
    500 mL SH30003
    IMDM
    with L-glutamine and HEPES • without alpha-thioglycerol
    500 mL SH30228
    MEM
    with Earle’s balanced salt solution (EBSS) and 2.0 mM L-glutamine
    500 mL SH30024
    HyQTase
    Cell detachment solutionҺɢҺ
    100 mL SV30030
    Trypan Blue Solution_{ȾɫҺ
    0.4% in phosphate buffered saline
    100 mL SV30084
    Gentamicin SolutionҺ
    50 mg/mL
    10 x 10 mL SV30080
    Antibiotic Antimycotic SolutionؿҺ
    (Pen/strep/fungizone), 100×
    100 mL SV30079
    Phosphate Buffered Saline (PBS}_Һ) 500 mL SH30256
    Dulbecco’s Phosphate Buffered Saline (DPBS) 500 mL SH30264
    HEPES
    1 M solution
    100 mL SH30237
    Earle’s Balanced Salt Solution (EBSSҺ)
    1×, with calcium, magnesium, phenol red
    500 mL SH30029
    Hank’s Balanced Salt Solution (HBSSҺ)
    1×, with calcium, magnesium, phenol red
    500 mL SH30030
    L-Glutamine
    0.25%
    500 mL SH30034
    NEAA 100 mL SH30238
    Cell Culture Grade Water
    oȶ(< 0.005 EU/mL), ox, ˮ, 100 nmo^V
    500 mL SH30529

    ¡FBSaƷfpdfPYd

    ¡FBSaƷe

    ] 7

    ȫ BcѪ

    ѪƷN

    PaƷ

    P

    P

    Copyright © 20012-2013 BIOFENG. L Powered by Biofeng
    gӭLԃ....
    富二代app最新安卓下载
  • <sub id="w5dj7"><xmp id="w5dj7"><track id="w5dj7"></track>
  • <option id="w5dj7"><li id="w5dj7"><option id="w5dj7"></option></li></option>
  • <xmp id="w5dj7"><center id="w5dj7"></center></xmp>
  • <sub id="w5dj7"></sub>
  • <sub id="w5dj7"></sub>
  • <progress id="w5dj7"><center id="w5dj7"><tbody id="w5dj7"></tbody></center></progress> <sub id="w5dj7"></sub>
  • <track id="w5dj7"><li id="w5dj7"></li></track>
  • <track id="w5dj7"><noframes id="w5dj7"><track id="w5dj7"></track>
  • <nav id="w5dj7"><xmp id="w5dj7"><track id="w5dj7"></track><track id="w5dj7"></track>